Ireland's Dunbar Supplies Plant-Derived Dronabinol to the UK Through IPS Pharma
Dunbar introduced plant-derived dronabinol to UK clinicians through IPS Pharma, using purified THC produced at its Irish EU-GMP facility for oral formulations. The launch illustrates a standardized pharmaceutical supply chain. It does not establish a new indication approval or NHS reimbursement.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
businessofcannabis.com
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://businessofcannabis.com/irelands-dunbar-pharma-launches-plant-derived-dronabinol-in-uk-through-ips-pharma/